BASF increases prices for Vitamin E and A feed grade
Advertisement
BASF increases prices for vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all vitamin A products. Existing contractual obligations with customers will be honored.
Most read news
Organizations
Other news from the department price development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Cell Medica granted Orphan Drug designation for novel cellular therapy

Drug costs vary by more than 600% in study of 10 high-income countries

Are the high prices of cancer drugs justified? - Does the cost correspond to the particular drug’s effectiveness in combating the disease?

Vetter Marks the Start of New Clinical Site Construction with Groundbreaking Ceremony - Vetter continues to expand in the US

A New Era Begins: BioSpring Builds High-Tech Manufacturing Facility for Pharmaceutical Nucleic Acid APIs

GEA invests EUR 80 million in a pharmaceutical technology center for freeze-drying systems in Germany - First product chambers in the “Factory of the Future”

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

ChatGPT grows insect-toxic genetically engineered plant - Blind spot in the EU draft law on genetic engineering

Commission launches new strategy to make Europe a global leader in life sciences by 2030

CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech - BioNTech’s acquisition of CureVac will be implemented as planned

Time out: We all need a three-day weekend - Researchers confirm health benefits
